GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Aarti Drugs (BOM:524348) Future 3-5Y EPS without NRI Growth Rate : N/A (As of Jan. 18, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Aarti Drugs Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Aarti Drugs's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Aarti Drugs's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Aarti Drugs's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aarti Drugs's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aarti Drugs's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Aarti Drugs's Future 3-5Y EPS without NRI Growth Rate falls into.


Aarti Drugs  (BOM:524348) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Aarti Drugs Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Aarti Drugs's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Aarti Drugs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (BOM:524348) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
BOM:500288 BOM:512529 BOM:509079 BOM:524735 NSE:RPGLIFE BOM:506879 BOM:506690 BOM:532612 BOM:541540 BOM:530239 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
AARTIDRUGS:India
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022
Website
https://www.aartidrugs.co.in
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.

Aarti Drugs Headlines

No Headlines